0001104659-23-068141.txt : 20230605 0001104659-23-068141.hdr.sgml : 20230605 20230605173531 ACCESSION NUMBER: 0001104659-23-068141 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230601 FILED AS OF DATE: 20230605 DATE AS OF CHANGE: 20230605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lubner David Charles CENTRAL INDEX KEY: 0001572000 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39373 FILM NUMBER: 23994027 MAIL ADDRESS: STREET 1: C/O TETRAPHASE PHARMACEUTICALS, INC. STREET 2: 480 ARSENAL STREET, SUITE 110 CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: POINT Biopharma Global Inc. CENTRAL INDEX KEY: 0001811764 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850800493 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4850 WEST 78TH STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46268 BUSINESS PHONE: (317) 543-9957 MAIL ADDRESS: STREET 1: 4850 WEST 78TH STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46268 FORMER COMPANY: FORMER CONFORMED NAME: Therapeutics Acquisition Corp. DATE OF NAME CHANGE: 20200511 4 1 tm2317857-1_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-06-01 0 0001811764 POINT Biopharma Global Inc. PNT 0001572000 Lubner David Charles 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 1 0 0 0 0 Stock Option (Right to Buy) 9.12 2023-06-01 4 A 0 44749 0.00 A 2029-06-01 Common Stock 44749 44749 D The option will vest 100% on the first anniversary of the grant date. /s/ William L. Demers, by Power of Attorney for David Charles Lubner 2023-06-05